/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S.
WIRE SERVICES/
WINNIPEG, Jan. 17, 2018 /CNW/ - Delta 9 Cannabis
Inc. (TSXV:NINE) ("Delta 9" or the "Company") is pleased
to announce that the TSX Venture Exchange (the "Exchange") has
approved the listing for trading of its common share purchase
warrants (the "Warrants") issued on December
28, 2017 pursuant to its short form prospectus offering.
There are currently 8,521,500 Warrants issued and outstanding. Each
Warrant entitles the holder thereof to purchase one common share of
the Company at a price of $3.25 per
share until June 28, 2020. The
Exchange has informed the Company that the Warrants will begin
trading at the opening of the Exchange on Wednesday, January 17, 2018 under the symbol
"NINE.WT".
About Delta 9 Cannabis Inc.
Delta 9's wholly-owned
subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of
medical marijuana pursuant to the ACMPR and operates an
approximately 80,000 square foot production facility in
Winnipeg, Manitoba, Canada. Delta
9's shares trade on the TSX Venture Exchange under the symbol
"NINE".
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Delta 9 Cannabis Inc.